Research
Jefferies Upgrades Inovio Pharmaceuticals to Buy From Hold, Adjusts PT to $3 From $1.80
Inovio Pharmaceuticals (INO) has an average rating of overweight and mean price target of $7.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
$INO
